Australian Clinical Labs Limited (ACL.AX)
AUD 3.06
(7.37%)
AUD 3.06
(7.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 282.76 Million AUD | -4.59% |
| 2023 | 296.36 Million AUD | 25.58% |
| 2022 | 236 Million AUD | -8.89% |
| 2021 | 259.02 Million AUD | 39.0% |
| 2020 | 186.35 Million AUD | 259.29% |
| 2019 | 51.86 Million AUD | 11.18% |
| 2018 | 46.65 Million AUD | 13.16% |
| 2017 | 41.22 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 200.32 Million AUD | -32.41% |
| 2024 Q4 | 282.76 Million AUD | 877.47% |
| 2024 Q2 | 302.09 Million AUD | 50.81% |
| 2024 FY | 282.76 Million AUD | -4.59% |
| 2024 Q3 | 28.92 Million AUD | -90.42% |
| 2023 Q1 | 209.64 Million AUD | -11.17% |
| 2023 FY | 296.36 Million AUD | 25.58% |
| 2023 Q2 | 306.94 Million AUD | 46.41% |
| 2023 Q4 | 296.36 Million AUD | 51.76% |
| 2023 Q3 | 195.27 Million AUD | -36.38% |
| 2022 Q2 | 238.51 Million AUD | 58.0% |
| 2022 Q1 | 150.95 Million AUD | -41.72% |
| 2022 FY | 236 Million AUD | -8.89% |
| 2022 Q4 | 236 Million AUD | 67.1% |
| 2022 Q3 | 141.23 Million AUD | -40.78% |
| 2021 FY | 259.02 Million AUD | 39.0% |
| 2021 Q4 | 259.02 Million AUD | 30.41% |
| 2021 Q3 | 198.62 Million AUD | -40.15% |
| 2021 Q2 | 331.85 Million AUD | 75.68% |
| 2021 Q1 | 188.9 Million AUD | 1.37% |
| 2020 Q4 | 186.35 Million AUD | 51.61% |
| 2020 Q3 | 122.91 Million AUD | 0.0% |
| 2020 Q1 | 5.13 Million AUD | 0.0% |
| 2020 FY | 186.35 Million AUD | 259.29% |
| 2019 FY | 51.86 Million AUD | 11.18% |
| 2018 FY | 46.65 Million AUD | 13.16% |
| 2017 FY | 41.22 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BCAL Diagnostics Limited | -5.83 Million AUD | 4948.767% |
| Genetic Signatures Limited | -35.03 Million AUD | 907.179% |
| Genetic Technologies Limited | -377.06 Thousand AUD | 75091.116% |
| Healius Limited | 1.53 Billion AUD | 81.612% |
| Imagion Biosystems Limited | 5.81 Million AUD | -4765.776% |
| Integral Diagnostics Limited | 315.35 Million AUD | 10.336% |
| INOVIQ Ltd | -8.69 Million AUD | 3350.847% |
| Microba Life Sciences Limited | -20.49 Million AUD | 1479.731% |
| Monash IVF Group Limited | 48.23 Million AUD | -486.256% |
| Rhythm Biosciences Limited | -545.67 Thousand AUD | 51919.035% |
| Sonic Healthcare Limited | 3.87 Billion AUD | 92.694% |